Search results

This paper aims to examine the impact of a board-level governance bundle (i.e. size, independence, expertise, meetings, gender diversity and multiple directorships) on the non-financial performance of National Health Service (NHS) hospitals – and, separately, by hospital type (i.e. trusts hospitals and foundation trusts hospitals).

A logit regression for panel data is used for a sample of 128 NHS trusts and foundation trusts across England from 2014 to 2018. The data was hand-collected from NHS hospitals’ annual reports and Care Quality Commission reports. The cancer waiting time target (i.e. 62-day cancer referral and treatment target) is used to measure non-financial performance.

The main findings for NHS hospitals indicate that multiple directorships positively and significantly affect non-financial performance. However, board expertise and gender diversity have a negative and significant influence. When the sample is partitioned, the results remain the same for the NHS foundation trusts hospitals. For NHS trust hospitals, except for multiple directorships having a positive and significant effect, all remaining governance attributes have an insignificant impact.

The findings have implications for policymakers and practitioners as they move to implement measures to improve hospital performance against the cancer waiting time targets in the English NHS.

To the best of the authors’ knowledge, this is the first study to examine the impact of corporate governance on cancer waiting time targets in public hospitals. Overall, this paper contributes to the corporate governance literature, especially in the context of public hospitals, and has significant practical and theoretical implications.

This paper aims to report the results of an investigation into the effect of aggregate and individual corporate governance factors on the financial performance of state-owned enterprises (SOEs) in Kenya.

The paper uses balanced panel data regression analysis on a sample of 45 SOEs in Kenya for a four-year period (2015–2018).

The panel data analysis results show that board meetings, board skill and gender diversity individual provisions of corporate governance are significantly and positively associated with capital budget realization ratio (CBRR). Moreover, the study finds that aggregate corporate governance disclosure index, board sub-committees, board size and independent non-executive directors are positive but insignificantly related to CBRR.

The current study is based on secondary data, other methods of knowledge inquiry such as interviews and questionnaires may provide additional insights on the effectiveness of corporate governance on financial performance.

Overall, the results imply that corporate governance influences the performance of SOEs in Kenya. The results suggest that Mwongozo Code of Corporate Governance provisions should be changed to increase the number of women representations on board and the number of directors with doctoral qualifications because of their positive impact on the financial performance of SOEs in Kenya. Also, policymakers with remit over SOEs should re-evaluate why other corporate governance appear not to have an impact with a view of making the necessary changes.

The paper contributes to the dearth of literature on the efficacy of corporate governance on the financial performance of SOEs in developing countries.

Hospitals’ corporate governance (CG) mechanisms oversee critical operational issues and evaluate the outcomes. This paper investigates the impact of CG (i.e. board size, board independence, board expertise, board meetings, board gender diversity, CEO gender, and academic directors) on the financial performance of English National Health Service (NHS) hospitals and separately by hospital type (i.e. trusts and foundation trusts).

The sample includes 128 NHS hospitals. The data were collected through document analysis and archival work from annual hospital reports from 2014 to 2018.

The findings indicate that board expertise, board meetings, board diversity, CEO gender, and academic directors significantly and negatively affect NHS hospitals’ financial performance. For NHS trusts, the results reveal that board expertise, board diversity, and CEO gender have a significant negative effect, while for NHS foundation trusts, only CEO gender has a significant negative impact.

Overall, this study contributes to the literature on the healthcare system. It holds significant practical implications for hospital governance and has important implications for theories.

This paper aims to document international evidence of the impact of a board-level governance bundle [size, independence, CEO duality, gender diversity and sustainability committee (SC)] on sustainability reporting (SR) and, separately, on its three dimensions (economic, environmental and social).

The sample includes 370 listed firms from 50 countries. A GRI standards-based disclosure index was constructed to quantify SR across various reporting media.

The baseline findings show that SC positively affects SR and its three dimensions. Board size also has a significant and positive impact on SR and two of its dimensions (economic and social). Similarly, board independence and CEO duality have a significant but negative association with SR and the same two dimensions. Finally, board gender diversity has no significant impact on SR and all its three dimensions.

The findings that only SC significantly influences SR, and its three dimensions, have important implications for corporate governance reforms internationally to improve SR in countries where such committees are not yet part of the board of directors’ sub-committees.

Overall, this study contributes to board characteristics–SR literature and holds significant theoretical and practical implications.